Brian Holmes is the first man in the UK and the fifth in the world to receive the treatment.

Results challenge view that high testosterone fuels prostate cancer growth ...

A personalized peptide vaccine slashed prostate-specific antigen levels by as much as 99.6% in some men with advanced prostate cancer, according to a phase II clinical trial conducted at Kurume ...

Germline testing can identify hereditary cancer, which leads to implications for family members, cascade testing for relatives, and starting surveillance and prevention measures: Genetic testing in ...

Read more about the factors that patients with prostate cancer value most in treatment decisions, as reported at EAU 2026.

But does it cost too much?

Early-stage prostate cancer rarely causes symptoms, making routine screening the most reliable way to catch it before it ...

Prostate-specific membrane androgen PET/CT can help clinicians intensify or de-escalate care for men with prostate cancer who have biochemical recurrence following radical prostatectomy.A ...

The addition of Zytiga (abiraterone) to Truqap (capivasertib) significantly prolonged radiographic progression-free survival (rPFS) in patients with PTEN-deficient metastatic hormone-sensitive ...

Scans that make prostate cancer cells glow can eliminate the need for invasive biopsies and cut false positive—and they're ...

Join the March for Men on Bournemouth seafront, 28 March, to raise funds for prostate cancer support in Dorset for University ...